2025-01-07 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Review

**1. Performance Comparison & Divergence:**

Eli Lilly and Co. (LLY) is a global pharmaceutical company.  The cumulative return of LLY is 548.64%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 117.62%. The difference is 431.0%, placing it at the 69.2nd percentile of historical divergence based on the provided data (max: 634.5%, min: -25.2%).  The Alpha consistently shows as 0.0 in the provided data, indicating the model's limitations in calculating alpha from this specific data.  Beta, however, shows a significant increase over time, indicating increasing sensitivity to market movements.

**2. Recent Price Movement:**

* **Closing Price:** $765.10
* **5-Day Moving Average:** $774.20
* **20-Day Moving Average:** $784.26
* **60-Day Moving Average:** $817.29

The current price is below all three moving averages, suggesting a potential downward trend in the short to medium term.


**3. Technical Indicators & Expected Return:**

* **RSI:** 40.11 (Approaching oversold territory, but not yet definitively so)
* **PPO:** 0.01 (Positive, but very close to neutral; suggesting limited momentum)
* **20-Day Relative Divergence:** -2.9% (Indicates a recent short-term price decline).
* **Expected Return (2+ years):** 127.2% (This represents a significant outperformance relative to the S&P 500 over the long term, assuming consistent performance).  The 765.10 price does not reflect a sharp up or down movement considering the context of other data.

**4. Recent Earnings Analysis:**

The provided earnings data shows significant volatility in EPS and relatively stable revenue.

* **Quarterly Revenue:** Revenue has generally trended upwards, but with some quarter-to-quarter fluctuations.
* **EPS Trends:**  EPS shows substantial swings, including a negative EPS in the last two reported quarters (2024-10-30 and 2023-11-02). Note that there is duplicate data for 2024-10-30.  A thorough analysis requires further clarification on this discrepancy. The significant increase from Q2 to Q3 (2024) is notable, and requires further investigation of the underlying factors.
* **Beats/Misses:** Without expectations data, it's impossible to determine if earnings beat or missed expectations.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remained relatively consistent over the past year, fluctuating around $9-11B. Profit margins are consistently high, hovering around 80%.
* **Capital and Profitability:**  Equity shows growth, though ROE exhibits significant volatility, ranging from -0.51% to 21.88%.  This variation warrants further investigation into the causes of such fluctuations.


**6. News and Recent Issues:**

This section requires additional information on recent news (within the last two days), market outlook, and analyst opinions to provide a complete analysis.


**7. Overall Analysis:**

LLY has significantly outperformed the S&P 500 over the long term, demonstrating strong historical returns. However, recent price action suggests a potential short-term downturn, indicated by the price being below its moving averages. While RSI is approaching oversold conditions, the PPO indicates limited momentum.  The substantial volatility in EPS and ROE requires careful consideration and further investigation of underlying factors driving these fluctuations.  Missing context about earnings expectations prevents a full evaluation of earnings performance.  A complete picture needs more recent news, analyst opinions, and clarification on the duplicated earnings data for October 30th, 2024. The long-term outlook remains positive based on the historical outperformance, but short-term risks should be considered.


**8. Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice.  Independent research and consultation with a financial advisor are strongly recommended before making any investment decisions.  The analysis highlights areas of concern which require further investigation before making conclusions.
